Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07739290
NA
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury
Sponsor: Beth Israel Deaconess Medical Center
View on ClinicalTrials.gov
Summary
The purpose of this single-center, randomized, double-blinded placebo-controlled pilot trial is to demonstrate feasibility and help design a larger trial to assess the effectiveness of nicotinamide (NAM) supplementation in reducing risk of post-operative AKI in patients undergoing cardiac surgery.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-09-01
Completion Date
2029-01-01
Last Updated
2026-07-31
Healthy Volunteers
No
Conditions
Interventions
DIETARY_SUPPLEMENT
Nicotinamide (NAM)
A one time 3000 mg nicotinamide dose administered orally on the morning of cardiac surgery
DIETARY_SUPPLEMENT
Placebo control
A visually identically placebo